National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 19 of 1998) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 19 of 1998

I, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration shall come into operation on 1 November 1998.

1. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Aluminium Hydroxide, Dried with Light Kaolin or Light Kaolin (Natural)

Aminophylline

Calcitonin (Human) – Synthetic

Methdilazine Hydrochloride

Orphenadrine Hydrochloride

_____________________________________________________________________

Dated this 14^th day of October 1998.

A. STEVENS

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Family Services

Delegate of the Minister for Health and Family Services